Prague will host the European Academy of Allergy and Clinical Immunology (EAACI) Congress in a hybrid format on 1–3 July 2022 at the O2 universum. The Prague Convention Bureau, in cooperation with the Czech Society of Allergology and Clinical Immunology won the bidding process after a three-year endeavor. The EAACI flagship congress is attended yearly by over 8,000 health care professionals and scientists including key opinion leaders from all over the world.
The European Academy of Allergy and Clinical Immunology (EAACI) is an association of more than 13,000 clinicians, researchers and allied health professionals from 124 countries, dedicated to improving the health of people affected by allergic diseases and asthma.
After the highly successful digital Congress in London in 2020 and the Hybrid Congress held in Krakow, Poland in 2021, the EAACI Congress 2022 will head to Prague, Czech Republic to be organized again in a hybrid format. “The hybrid format brings many new advantages and progressive functionalities, as was experienced during the first EAACI Hybrid Congress in 2021. It allows participants to attend and network from all around the globe, but we would also like to express our wish to have as many participants as possible with us personally in Prague, to enjoy both the social contact with friends and colleagues and the unique scientific and cultural atmosphere that the magical Prague has to offer,” says prof. MUDr. Petr Panzner CSc., local ambassador and Chair of the 2022 Congress.
The topic of the 2022 EAACI Congress is “Common origins of allergy and chronic inflammatory diseases – the One Health approach”. During the three-day program, delegates will have a chance to attend more than 200 expert presentations and interactive workshops delivered by key opinion leaders and high-level speakers.
“The One Health Approach corresponds to determining of the links between human health and all environmental factors such as pollution, climate change, animal health and many more. It will be very stimulating and exciting to discuss these topics during the hybrid Congress. I am convinced that the 2022 scientific programme will not only help participants to gather the updated scientific information but will be very helpful in their daily practice as physicians and other HCPs thanks to interactive workshops and meet-the-expert sessions”, says Prof. Panzner.
“A multitude of common factors seems to be responsible for allergic diseases development, duration, and severity. All these factors may have a varying influence on development and outcome of allergic diseases. Therefore, to successfully combine them, a well-coordinated approach both in humans and in animals is necessary. This involves a joint effort from all stakeholders, forging collaborations among various disciplines, governmental bodies, industry, and patients. There is no better place to bring all these minds together than the EAACI hybrid Congress 2022, which will provide three days of intensive knowledge sharing, world-class lectures by our experts, and the possibility to brainstorm on these linkages, priorities, and challenges as the interdisciplinary community we are,” says Prof. Marek Jutel, EAACI President.